Log In
BCIQ
Print this Print this
 

Traumakine (FP-1201, FP-1201-lyo, MR11A8)

  Manage Alerts
Collapse Summary General Information
Company Faron Pharmaceuticals Oy
DescriptionRecombinant human interferon (IFN) beta-1a
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$5.7M

$0.9M

0


 Deals Details
Get a free BioCentury trial today